Skip to main content
. 2022 Apr 7;36(5):594–603. doi: 10.1177/02698811221082470

Figure 3.

Figure 3.

Incidence of primary outcome treated depression and nonfatal and fatal self-harm according to subgroups.

ACEI: angiotensin-converting enzyme inhibitor; ARB: angiotensin II receptor antagonist; DDD: defined daily dose.

For lipophilic and less lipophilic ACEIs/ARBs, please see Supplemental Material, eTable 2.